With Bracco Imaging, NTP Radioisotopes, GE Healthcare and more

Global Nuclear Medicine Market

Dublin, December 22, 2022 (GLOBE NEWSWIRE) — The “Global Nuclear Medicine Market Report 2022: Impact of the Ukraine-Russia War” report has been added to researchandmarkets.com offering.

The global nuclear medicine market is expected to grow from $6 billion in 2021 to $6.77 billion in 2022 at a compound annual growth rate (CAGR) of 12.9%. The nuclear medicine market is expected to grow to $11.20 billion by 2026 at a CAGR of 13.4%.

The main types of nuclear medicine are diagnostic and therapeutic. A diagnosis is an examination to identify the different areas of strength and weakness of a person to identify a condition, disease or illness. The applications involved cardiology, lymphoma, thyroid, neurology, oncology, and other applications. End users included hospitals and clinics, diagnostic centers, and other end users.

North America was the largest region in the nuclear medicine market in 2021. Asia-Pacific is expected to be the fastest growing region in the forecast period. Regions covered in this nuclear medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The increasing constancy and prevalence of cardiovascular disease (CVD) and cancer is expected to fuel the growth of the nuclear medicine market in the future. Cardiovascular diseases (CVD) are a group of disorders of the heart and blood vessels, and cancer is a disease in which cells grow out of control and spread to other parts of the body. Nuclear cardiac imaging can help diagnose heart disease more quickly. Nuclear medicine therapy is a method of treating cancer that can be used with or after other therapy options, such as surgery and chemotherapy.

As a result, the increasing constancy and prevalence of cardiovascular diseases and cancer increase market demand for nuclear medicine. For example, in 2020, according to GLOBOCAN, a US-based cancer observatory, there were 19.29 thousand new cases of cancer in the world in the year 2020, and 28.88 thousand cases are anticipated for 2040. In addition , in 2019, according to World The World Health Organization (WHO), a Swiss-based international organization responsible for public health, estimates that 17.9 million people worldwide died from cardiovascular disease (CVD) in 2019, representing 32% of all deaths. 85% of these deaths were caused by heart attacks and strokes. Therefore, the increasing constancy and prevalence of cardiovascular disease and cancer are driving the nuclear medicine market.

Product innovation is the key trend gaining popularity in the nuclear medicine market. The main companies operating in the nuclear medicine market focus on the development of innovative new products to strengthen their position.

the story continues

For example, in March 2021, GE Healthcare, a US-based company dealing with nuclear medicine, launched Star Guide, a new nuclear medicine system to help advance healthcare and precision theranostics. . StarGuide uses the latest developments in cadmium zinc telluride (CZT) technology to help providers explore and better understand a patient’s condition, improving patient outcomes throughout the continuum of care. It has unique features such as digital focus detectors and 360-degree imaging of the system that are intended to support enhanced theranostic capabilities in advanced precision healthcare and nuclear medicine.

Reasons to buy

• Get a truly global perspective with the most comprehensive report available on this market covering more than 12 geographies.

• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus lessens.

• Russia assessment: impact of the war on the supply of agricultural, energy and mineral commodities and its direct and indirect impact on the market analyzed in the report.

• Impact of high world inflation on market growth.

• Create regional and national strategies based on local data and analysis.

• Identify growth segments for investment.

• Outperform competitors using forecast data and the drivers and trends that shape the market.

• Understand customers based on the latest market research findings.

• Compare performance with key competitors.

• Use the relationships between key data sets for superior strategy.

• Suitable for supporting your internal and external presentations with reliable, high-quality data and analysis

• All report data will also be delivered in excel format.

Scope
Markets covered:

1) By Type: Diagnosis; Therapeutic
2) By Application: Cardiology; lymphomia; Thyroid; Neurology; Oncology; other application
3) By End User: Hospitals and Clinics; Diagnostic Centers; Other end users

Key topics covered:

1. Executive Summary

2. Characteristics of the nuclear medicine market

3. Nuclear Medicine Market Trends and Strategies

4. Nuclear Medicine Market – Macroeconomic Scenario

5. Nuclear Medicine Market Size and Growth

6. Segmentation of the nuclear medicine market

7. Country and Regional Analysis of the Nuclear Medicine Market

8. Asia-Pacific Nuclear Medicine Market

9. China Nuclear Medicine Market

10. India Nuclear Medicine Market

11. Japan Nuclear Medicine Market

12. Australian Nuclear Medicine Market

13. Indonesian Nuclear Medicine Market

14. South Korea Nuclear Medicine Market

15. Western Europe Nuclear Medicine Market

16. UK Nuclear Medicine Market

17. Germany Nuclear Medicine Market

18. France Nuclear Medicine Market

19. Eastern European Nuclear Medicine Market

20. Russian Nuclear Medicine Market

21. North America Nuclear Medicine Market

22. US Nuclear Medicine Market

23. South America Nuclear Medicine Market

24. Brazil Nuclear Medicine Market

25. Middle East Nuclear Medicine Market

26. Africa Nuclear Medicine Market

27. Nuclear Medicine Market Competitive Landscape and Company Profiles

28. Key mergers and acquisitions in the nuclear medicine market

29. Nuclear Medicine Market Future Prospects and Potential Analysis

30. Appendix

Mentioned companies

• SPA of images Bracco

• Lantheus Medical Imaging Inc.

• NTP Radioisotopes SOC Ltd

• Eckert & Ziegler Group

• Jubilant Pharma LLC

• Australian Nuclear Science and Technology Organization

• cardinal health inc

• GE Health

• Curium Pharma7

• Advanced Accelerator Applications

• Nordion Inc.

• radioelements institute

• Eczacibasi-Monrol

• Siemens Healthineers AG

• Cambridge Isotope Laboratories Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/mb0gr9

Attached file

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900